Literature DB >> 2117266

Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.

J Modha1, J R Lambertucci, M J Doenhoff, D J McLaren.   

Abstract

This study examines the immune-dependence of praziquantel (PZQ) for the treatment of Schistosomiasis mansoni in mice. We have shown elsewhere from worm recovery data that the efficacy of PZQ is significantly enhanced when mice are treated concomitantly with antisera raised against antigens released from adult schistosomes, even though such antisera show no intrinsic helminthotoxic activity (Doenhoff et al. 1987, Doenhoff, Modha & Lambertucci 1988). Moreover, indirect immunofluorescence assays have shown that male worms exposed to the dual treatment regime in vivo bind antiserum to their dorsal surfaces in a pattern that seems to follow the outline of the dorsal tubercles. Scanning and transmission electron microscopy have now been used to further define the features of damage inflicted upon worms through exposure to antiserum alone, drug alone, or the two treatments in combination. Such investigations revealed that the antiserum induces a classical membrane repair process in worms of both sexes, but little other damage. PZQ causes the formation of spherical protuberances on the dorsal tubercles of male worms, while the dual treatment regime induces both kinds of damage in male schistosomes, but with much enhanced severity. The protuberances show evidence of explosion and some regions of the tegument become completely destroyed. Regions other than the dorsal surfaces of the male worms do not exhibit comparable trauma, and neither do the females. These data are discussed in relation to the known schistosomicidal activity of PZQ, the notion that male and female worms exhibit regional and sexual differences in susceptibility, documented evasive strategies of the parasite and the interdependence of immuno- and chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117266     DOI: 10.1111/j.1365-3024.1990.tb00958.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  8 in total

1.  Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.

Authors:  Maysa Ahmad Eraky; Asmaa Abd El-Monem El-Kholy; Gehan Abd El-Rahman Rashed; Olfat Ali Hammam; Ahlam Farag Moharam; Eman Abdel-Rahman Abou-Ouf; Nagwa Shaban Mohammed Aly; Shereen Magdy Kishik; Karim Fetouh Abdallah; Dalia Ibrahim Hamdan
Journal:  Parasitol Res       Date:  2016-06-20       Impact factor: 2.289

2.  Quantification of praziquantel-induced damage on the surface of adult Schistosoma mansoni worms: estimation of esterase and alkaline phosphatase activity.

Authors:  P G Fallon; C McNeice; A J Probert; M J Doenhoff
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

Review 3.  Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Amel el-Sahn; Azza Hassan
Journal:  Parasitol Res       Date:  2009-03-03       Impact factor: 2.289

4.  Praziquantel efficacy against Schistosoma mansoni among HIV-1 infected and uninfected adults living in fishing villages along Lake Victoria, Northwest Tanzania.

Authors:  Humphrey D Mazigo; David W Dunne; Safari M Kinung'hi; Fred Nuwaha
Journal:  Infect Dis Poverty       Date:  2014-12-15       Impact factor: 4.520

5.  Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial.

Authors:  Robert Tweyongyere; Patrice A Mawa; Sophy Ngom-Wegi; Juliet Ndibazza; Trinh Duong; Birgitte J Vennervald; David W Dunne; Eli Katunguka-Rwakishaya; Alison M Elliott
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

6.  Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.

Authors:  Carla L Black; Michelle L Steinauer; Pauline N M Mwinzi; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Trop Med Int Health       Date:  2009-02-14       Impact factor: 2.622

7.  Epidemiology and interactions of Human Immunodeficiency Virus - 1 and Schistosoma mansoni in sub-Saharan Africa.

Authors:  Humphrey D Mazigo; Fred Nuwaha; Shona Wilson; Safari M Kinung'hi; Domenica Morona; Rebecca Waihenya; Jorg Heukelbach; David W Dunne
Journal:  Infect Dis Poverty       Date:  2013-01-24       Impact factor: 4.520

8.  New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel.

Authors:  Martin Walker; Tarub S Mabud; Piero L Olliaro; Jean T Coulibaly; Charles H King; Giovanna Raso; Alexandra U Scherrer; J Russell Stothard; José Carlos Sousa-Figueiredo; Katarina Stete; Jürg Utzinger; Maria-Gloria Basáñez
Journal:  Parasit Vectors       Date:  2016-01-27       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.